Gold prices bounce off 3-week lows; demand likely longer term
Investing.com - Rapid Micro Biosystems reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Rapid Micro Biosystems announced earnings per share of $-0.38 on revenue of $4.74M. Analysts polled by Investing.com EPS of $-0.35 on revenue of $6.05M.
Rapid Micro Biosystems 's are down 24% and is trading at $2.75 , still down 88.02% from its 52 week high of $21.86 set on Thursday, November 11, 2021.
Rapid Micro Biosystems shares gained 4.96% to trade at $2.75 in pre-market trade the report.
Rapid Micro Biosystems follows other major Healthcare sector earnings this month
Rapid Micro Biosystems's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar